FDA Drug Recalls

Recalls / Class II

Class IID-0210-2026

Product

Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.

Brand name
Clotrimazole
Generic name
Clotrimazole
Active ingredient
Clotrimazole
Route
Topical
NDC
69396-087
FDA application
M005
Affected lot / code info
Lot #: A472408

Why it was recalled

cGMP deviations

Recalling firm

Firm
Blossom Pharmaceuticals
Manufacturer
TRIFECTA PHARMACEUTICALS USA LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
Plot No. 21/22 Bardez Blossom Pharmaceuticals Karaswada-Tivim, Bardej, Goa, N/A, India

Distribution

Quantity
12150 bottles
Distribution pattern
USA Nationwide

Timeline

Recall initiated
2025-10-31
FDA classified
2025-12-02
Posted by FDA
2025-12-10
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0210-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.